Bio-key International Inc. reports a 49% revenue increase in Q2 2025, driven by growth across all segments, and announces strategic expansions through new partnerships and initiatives in the biometric security space.

Bio-Key International’s stock price has plummeted to $0.79 USD, with a negative price-to-earnings ratio and declining stock performance raising concerns about the company’s ability to deliver value to shareholders and its long-term sustainability.